Search
Now showing items 1-10 of 270
Menopause or climacteric, just a semantic discussion or has it clinical implications?
(Informa Healthcare, 2014)
Climacteric and menopause are two terms that are indistinctly used to name clinical expected events related to the decline in ovarian function. Thus, in the literature and in clinical settings we read and hear 'menopausal ...
Metabolic Syndrome and Mammographic Density in Premenopausal Chilean Women
(2017)
Background: Metabolic syndrome (MetS) has been previously associated with an increased risk of breast cancer in postmenopausal women. Mammographic density (MD) is a marker of breast cancer risk. There is little evidence ...
Metabolic Syndrome and Mammographic Density in Premenopausal Chilean Women
(Routledge, 2017)
Background: Metabolic syndrome (MetS) has been previously associated with an increased risk of
breast cancer in postmenopausal women. Mammographic density (MD) is a marker of breast cancer
risk. There is little evidence ...
Risk of vascular disease in premenopausal women with diabetes mellitus
(Elsevier Science, 2014-12)
Purpose: The aims of this study were (1) to estimate the prevalence of cardiovascular disease risk factors among premenopausal and menopausal Argentinean women with and without type 2 diabetes mellitus and (2) to assess ...
Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients
(ELSEVIER SCIENCE INC, 2009)
Objective: To assess the effect of the aromatase inhibitor on patients with leiomyoma in the reproductive stage regarding reduction of uterine volume and control of symptoms. Design: Clinical study. Setting: Academic ...